Science Explorer Back to mapMap
Discussion
Researcher · Evotec (Germany) · Germany

Mark J. Gemkow

Mark J. Gemkow publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology, on topics such as Cannabis and Cannabinoid Research, Pharmacological Receptor Mechanisms and Effects and Neurotransmitter Receptor Influence on Behavior.

OpenAlex
World rank
#4,333,023
of 7,710,434 ranked researchers
Rank in Germany
#219,561
of 364,343
Works
15
Citations
495
Citations per work
33.0
h-index
12
i10-index 12Top 65% in Molecular Biology
Mark J. Gemkow

What does Mark J. Gemkow research?

Mark J. Gemkow's work is mostly in Biochemistry, Genetics and Molecular Biology (28%), Medicine (21%), Neuroscience (19%).

Life Sciences: 9 works · 58.2% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 27.9% of their workMolecular Biology: 4 works · 27.9% of their workNeuroscience: 3 works · 18.6% of their workCellular and Molecular Neuroscience: 3 works · 18.6% of their workImmunology and Microbiology: 1 works · 7.0% of their workImmunology: 1 works · 7.0% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 4.7% of their workToxicology: 1 works · 4.7% of their workHealth Sciences: 3 works · 20.9% of their workMedicine: 3 works · 20.9% of their workPharmacology: 3 works · 18.6% of their workReproductive Medicine: 0 works · 2.3% of their workEverything else: 3 works · 20.9% of their workTHEIR WORKMark J. Gemkow15works
Life Sciences58%Health Sciences21%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology427.9%
    2. Neuroscience318.6%
    3. Immunology and Microbiology17.0%
    4. Pharmacology, Toxicology and Pharmaceutics14.7%
    1. Medicine320.9%
  3. Everything else320.9%
  1. 1Molecular Biology28% of their works
  2. 2Cellular and Molecular Neuroscience19% of their works
  3. 3Pharmacology19% of their works
  4. 4Immunology7% of their works
  5. 5Toxicology5% of their works
  6. 6Reproductive Medicine2% of their works

Research topics

Which keywords describe Mark J. Gemkow's research?

The keywords of their largest research topics: Neuroprotection, Neurological Disorders, Cannabinoid Receptors, Endocannabinoid System, Chaperone, Sigma-1 Receptor, Dopamine and Serotonin.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Neuroprotection122 topics
  2. Neurological Disorders92 topics
  3. Cannabinoid Receptors71 topic
  4. Endocannabinoid System71 topic
  5. Chaperone51 topic
  6. Sigma-1 Receptor51 topic
  7. Dopamine41 topic
  8. Serotonin41 topic
  9. Allergic Disease31 topic
  10. Crystal Structure31 topic
  11. G-Protein-Coupled Receptors31 topic
  12. Mast Cells31 topic
  13. Drug Analysis21 topic
  14. Forensic Toxicology21 topic
  15. Huntington's Disease21 topic
  16. Neurotransmission21 topic
  17. Protein Aggregation21 topic
  18. Synaptic Plasticity21 topic

Where does Mark J. Gemkow work?

Mark J. Gemkow's main affiliation in the publication record is Evotec (Germany), Germany.

How many publications and citations does Mark J. Gemkow have?

OpenAlex counts 15 works and 495 citations for Mark J. Gemkow, an h-index of 12, ranking #4,333,023 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark J. Gemkow. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.